The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
2022 · Annals of Oncology · 435 citations
https://doi.org/10.1016/j.annonc.2022.04.007
L
Lorraine Warrington
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.4K
Citations
11
h-index
11
i10-index
Lorraine Warrington is an academic researcher from University of Leeds. The author has contributed to research in topics: Cancer survivorship and care & Economic and Financial Impacts of Cancer & Patient-Provider Communication in Healthcare. The author has an h-index of 11, co-authored 24 publications.
ORCID: 0000-0002-8389-6134Papers by this author
worksPhase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
2021 · Journal of Clinical Oncology · 294 citations
https://doi.org/10.1200/jco.20.02015
Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment
2017 · Annals of Oncology · 131 citations
https://doi.org/10.1093/annonc/mdx317
Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting
2019 · BMJ Open · 40 citations
https://doi.org/10.1136/bmjopen-2018-025185
Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)—An eHealth intervention during chemotherapy.
2020 · Journal of Clinical Oncology · 14 citations
https://doi.org/10.1200/jco.2020.38.15_suppl.7002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat